Tandem Diabetes Care's new Tandem Mobi insulin pump is the first to offer both tubed and tubeless options.

Nov 13, 2026, 1:34 PM ETProductRead the original at Benzinga

Good for TNDM

Tandem gained FDA clearance for a tubeless Mobi option, giving customers both tubed and tubeless choices. Sales are not planned until the first half of 2027, and pharmacy coverage reaches roughly 50% of insured U.S. lives today, but the new choice makes Mobi stand out.

TNDM · Tandem Diabetes Care, Inc.

AI read · Good for TNDM

The AI's read

More wear choices could help Tandem reach people who want fewer site changes. The same pump can now be used with tubed or tubeless sets. The benefit will take time to reach customers: U.S. sales are planned for the first half of 2027. Pharmacy benefits cover roughly 50% of insured people today, though Tandem expects that share to grow.

Get alerts for TNDM

Follow Tandem Diabetes Care, Inc. (TNDM) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for TNDM

Free on the App Store and Google Play, or on the web.